Log in to save to my catalogue

Pharmacotherapies for Migraine and Translating Evidence from Bench to Bedside

Pharmacotherapies for Migraine and Translating Evidence from Bench to Bedside

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2922447420

Pharmacotherapies for Migraine and Translating Evidence from Bench to Bedside

About this item

Full title

Pharmacotherapies for Migraine and Translating Evidence from Bench to Bedside

Publisher

England: Elsevier Inc

Journal title

Mayo Clinic proceedings, 2024-02, Vol.99 (2), p.285-299

Language

English

Formats

Publication information

Publisher

England: Elsevier Inc

More information

Scope and Contents

Contents

Migraine is a ubiquitous neurological disorder that afflicts more than one billion people worldwide. Recommended therapeutic strategies include the use of acute and, if needed, preventive medications. Over the past two decades, tremendous progress has been made in better understanding the molecular mechanisms underlying migraine pathogenesis which,...

Alternative Titles

Full title

Pharmacotherapies for Migraine and Translating Evidence from Bench to Bedside

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2922447420

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2922447420

Other Identifiers

ISSN

0025-6196

E-ISSN

1942-5546

DOI

10.1016/j.mayocp.2023.07.003

How to access this item